Reactions 1680, p305 - 2 Dec 2017 Mild skin irritation: case report An 84-year-old woman developed mild skin irritation following treatment with selegiline [Emsam] and haloperidol [Haldol]. The woman, who had depression, started to receive transdermal selegiline 6 mg/day. Later, topical haloperidol gel 0.5mg twice daily was added due to her agitation and aggressive behaviours. Following three weeks of selegiline therapy, her depressive symptoms improved; however, she experienced mild skin irritation, which eventually resolved [durations of treatments to reaction onset not stated]. Her resistive behaviours continued especially at night; therefore, haloperidol at bedtime was increased to 1mg. The depressive symptoms returned after 8 months. She was maintained on topical gels till she died of end-stage cardiac disease in February 2015. Author comment: "There were no side effects noted except for mild skin irritation that resolved." Patterson KT. Using transdermal administration of psychiatric medications to enhance quality of life in an elderly nursing home patient diagnosed with dementia and depression: A case study. CNS Spectrums 21: 108-109, No. 1, Feb 2016. Available from: URL: http://doi.org/10.1017/S1092852915000905 [abstract] - USA 803284897 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera